Advertisement
News
Subscribe to MDT Magazine News

MSD Wellcome Trust Hilleman Laboratories announces first project

January 24, 2011 8:33 pm | by EurekAlert | Comments

(MSD Wellcome Trust Hilleman Laboratories) MSD Wellcome Trust Hilleman Laboratories announced that the organization's first project will be a feasibility study into how new technologies might be used to develop a rotavirus vaccine designed with developing country needs in mind....

TOPICS:

Two Laser Balloon 'Live Cases' Shed New Light on Direct Visualization and PV Ablation

January 24, 2011 6:35 pm | by Bio-Medicine.Org | Comments

MARLBOROUGH, Mass., Jan. 24, 2011 /- CardioFocus announced that two "live cases" using its Endoscopic Ablation System were recently conducted. The first live case was a satellite transmission performed at Centro Cardiologico Monzino in Milan, Italy; broadcast to the 16th Annual Boston...

TOPICS:

Summary Box: Amgen reports earnings, BioVex deal

January 24, 2011 1:45 pm | by The Associated Press | Comments

INFECTION DRUGS: Amgen Inc. said its profit rose 10 percent in the fourth quarter on better sales of its drugs Neulasta and Neupogen, which fight infections in patients on chemotherapy. Sales of the two drugs grew 3 percent to $1.24 billion.NEW PRODUCTS: Combined sales of its bone drugs Prolia and...

Advertisement

Novartis Offers $470M for Genoptix

January 24, 2011 1:34 pm | by San Diego Business Journal | Comments

The international pharmaceutical company Novartis AG said early Jan. 24 that it has agreed to buy Genoptix Inc., a Carlsbad-based specialty lab, for $470 million in cash.

TOPICS:

Amgen 4Q profit up 10 percent on Neulasta sales

January 24, 2011 11:45 am | by The Associated Press | Comments

Biotechnology company Amgen Inc. says its profit rose 10 percent in the fourth quarter on better sales of anti-infection drugs and reduced taxes.The Thousand Oaks, Calif., company says its earned $1.02 billion, or $1.08 per share, from $931 million, or 92 cents per share. Excluding one-time...

Surgery aims to tackle depression

January 24, 2011 11:44 am | by BBC | Comments

A medical team at Frenchay Hospital in Bristol is pioneering a new form of surgery to treat long term depression.

TOPICS:

Clinical Data depression drug gets FDA approval

January 24, 2011 11:43 am | by Mass High Tech: The Journal of New England Technology | Comments

Newton drug developer Clinical Data Inc. has received U.S. Food and Drug Administration approval for its vilazodone HCl tablets to treat adults with major depressive disorder (MDD).

Athersys, Inc. - Retail Investor Conferences.com Presentation Now Available Online

January 24, 2011 11:36 am | by Bio-Medicine.Org | Comments

CLEVELAND, Jan. 24, 2011 /- Athersys, Inc. (Nasdaq: ATHX ), a clinical stage biopharmaceutical company, today announced that its January 11th Retail Investor Conferences.com presentation is available for on-demand viewing.  Gil Van Bokkelen, PhD, Chairman and Chief Executive Officer...

TOPICS:
Advertisement

Study examines earlier use of heart pumps in growing group of heart failure patients

January 24, 2011 11:34 am | by EurekAlert | Comments

(University of Michigan Health System) The University of Michigan Cardiovascular Center and the University of Pittsburgh have been awarded $13.3 million to explore the potential benefits of heart devices for the large and growing group of Americans with heart failure. The NIH and...

TOPICS:

Mylan's Matrix Receives Approval for Generic Version of Protonix® Delayed-release Tablets

January 24, 2011 11:34 am | by Bio-Medicine.Org | Comments

PITTSBURGH, Jan. 24, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Pantoprazole Sodium Delayed-release (DR)...

TOPICS:

Survey Finds Patients Oppose Prescription Mandate for OTC Medicines Containing Pseudoephedrine

January 24, 2011 11:34 am | by Bio-Medicine.Org | Comments

WASHINGTON, Jan. 24, 2011 /PRNewswire-USNewswire/ -- More than 300 million Americans get the common cold, and up to 70 million get the flu annually. But for the 60 million people who also have asthma and allergies, a cold or flu can pose even greater risks. Together, these respiratory...

TOPICS:

Genelux Corporation Expands Board of Directors, Appointing Dennis Fenton, Former Amgen Executive

January 24, 2011 11:33 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Jan. 24, 2011 /- Genelux Corporation, a privately held, clinical stage biopharmaceutical company developing diagnostic and therapeutic solutions for cancer and inflammatory diseases, today announced the appointment of Dr. Dennis Fenton, long-time Amgen executive, to the...

TOPICS:

Not Resting on Its Laurels, Startup Focusing on Sleep Disorders

January 24, 2011 8:32 am | by San Diego Business Journal | Comments

With business partners such as Roche and Stanford University already on board to test its wireless brain recording technology, NeuroVigil Inc. is looking to make some other smart moves in 2011.

TOPICS:

Materials for the January 26, 2011 Circulatory System Devices Panel Meeting

January 24, 2011 8:30 am | by U.S. Food & Drug Administration | Comments

Added FDA generated and non-FDA generated materials.

TOPICS:

Introduction of TomoTherapy Treatments at New Ballard, Wash. Facility Delivers Flexibility in Treating Wide Range of Cancers

January 24, 2011 7:45 am | by The Associated Press | Comments

http://www.tomotherapy.com () —TomoTherapy Incorporated (http://www.tomotherapy.com/) (NASDAQ: TOMO), maker of advanced radiation therapy solutions for the treatment of cancer and other diseases, today announced that Swedish Cancer Institute (SCI)...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading